Real-time enrollment status for this hiv-1-infection clinical trial
Current Status
Recruiting
Checked: November 15, 2026 at 2:54 PM UTC
| NCT Number | NCT07708727 |
| Recruiting Status | Recruiting |
| Condition | HIV-1-infection |
| Phase | PHASE2 |
| Target Enrollment | 700 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | November 10, 2026 (5 days ago) |
As of November 15, 2026: Clinical trial NCT07708727 is currently recruiting participants. This phase2 study for hiv-1-infection is actively seeking new participants at 15 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07708727 is actively recruiting participants as of November 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07708727 was last updated 5 days ago (November 10, 2026). HelloStudys verifies this status automatically.